These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 30788118

  • 1. Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.
    Sagrini E, Iavarone M, Stefanini F, Tovoli F, Vavassori S, Maggioni M, Renzulli M, Salvatore V, Stefanescu H, Colombo M, Bolondi L, Piscaglia F.
    United European Gastroenterol J; 2019 Feb; 7(1):69-77. PubMed ID: 30788118
    [Abstract] [Full Text] [Related]

  • 2. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E, Iavarone M, Pompili M, Veronese L, Cabibbo G, Fraquelli M, Riccardi L, De Bonis L, Sangiovanni A, Leoni S, Zocco MA, Rossi S, Alessi N, Wilson SR, Piscaglia F, CEUS LI-RADS Italy study group collaborators:.
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [Abstract] [Full Text] [Related]

  • 3. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound.
    Galassi M, Iavarone M, Rossi S, Bota S, Vavassori S, Rosa L, Leoni S, Venerandi L, Marinelli S, Sangiovanni A, Veronese L, Fraquelli M, Granito A, Golfieri R, Colombo M, Bolondi L, Piscaglia F.
    Liver Int; 2013 May; 33(5):771-9. PubMed ID: 23445369
    [Abstract] [Full Text] [Related]

  • 4. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.
    Vilana R, Forner A, Bianchi L, García-Criado A, Rimola J, de Lope CR, Reig M, Ayuso C, Brú C, Bruix J.
    Hepatology; 2010 Jun; 51(6):2020-9. PubMed ID: 20512990
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ, Lee JM, Han JK, Kim KH, Lee JY, Choi BI.
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [Abstract] [Full Text] [Related]

  • 7. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B, Wildner D, Pfeifer L, Goertz RS, Hagel A, Neurath MF, Strobel D.
    Ultraschall Med; 2016 Dec; 37(6):627-634. PubMed ID: 27486793
    [Abstract] [Full Text] [Related]

  • 8. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW, Huang Y, Chen LD, Wang Z, Yang Z, Liu JY, Xie XY, Lu MD, Shen SL, Wang W.
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [Abstract] [Full Text] [Related]

  • 9. Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma.
    Viganò L, Lleo A, Muglia R, Gennaro N, Samà L, Colapietro F, Roncalli M, Aghemo A, Chiti A, Di Tommaso L, Solbiati L, Colombo M, Torzilli G.
    Updates Surg; 2020 Jun; 72(2):413-421. PubMed ID: 32323164
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
    Li R, Yang D, Tang CL, Cai P, Ma KS, Ding SY, Zhang XH, Guo DY, Yan XC.
    BMC Cancer; 2016 Feb 25; 16():158. PubMed ID: 26917546
    [Abstract] [Full Text] [Related]

  • 12. Detailed analysis of temporal features on contrast enhanced ultrasound may help differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma in cirrhosis.
    Li R, Yuan MX, Ma KS, Li XW, Tang CL, Zhang XH, Guo DY, Yan XC.
    PLoS One; 2014 Feb 25; 9(5):e98612. PubMed ID: 24874413
    [Abstract] [Full Text] [Related]

  • 13. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
    Iavarone M, Viganò M, Piazza N, Occhipinti V, Sangiovanni A, Maggioni M, D'Ambrosio G, Forzenigo LV, Motta F, Lampertico P, Rumi MG, Colombo M.
    Ann Hepatol; 2019 Feb 25; 18(2):318-324. PubMed ID: 31036496
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S, Isoda H, Shimizu T, Tamada D, Taura K, Togashi K, Onishi H, Motosugi U.
    Eur Radiol; 2020 Nov 25; 30(11):5992-6002. PubMed ID: 32500195
    [Abstract] [Full Text] [Related]

  • 16. CEUS and HCC: are the 2008 EFSUMB guidelines still valid or has their wash-out already started?
    Giorgio A, Calisti G, Giorgio V.
    Ultraschall Med; 2011 Jun 25; 32(3):315-6. PubMed ID: 21667409
    [No Abstract] [Full Text] [Related]

  • 17. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ, Chen WX, Wu DS, Zhang WY, Zheng LR.
    Abdom Radiol (NY); 2016 May 25; 41(5):978-89. PubMed ID: 27193795
    [Abstract] [Full Text] [Related]

  • 18. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
    Choi SH, Lee SS, Kim SY, Park SH, Park SH, Kim KM, Hong SM, Yu E, Lee MG.
    Radiology; 2017 Mar 25; 282(3):771-781. PubMed ID: 27797675
    [Abstract] [Full Text] [Related]

  • 19. Imaging features of combined hepatocellular-cholangiocarcinoma on contrast-enhanced ultrasound: correlation with clinicopathological findings.
    Ye J, Xie X, Lin Y, Liu B, Wang W, Huang X, Huang G.
    Clin Radiol; 2018 Mar 25; 73(3):237-243. PubMed ID: 29122222
    [Abstract] [Full Text] [Related]

  • 20. Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.
    Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Goertz RS, Cavallaro A, Janka R, Neurath MF, Uder M, Seuss H.
    Eur Radiol; 2018 Oct 25; 28(10):4254-4264. PubMed ID: 29675659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.